References
- Suraneni MV, Reddy GV, Pallu R. NSAIDs, COXIBs, CLOXIBs and cancer pain. Horizons Cancer Res 2012;47:253–70
- Townsed KP, Patricò D. Novel therapeutic opportunities for Alheimer’s disease: focus on nonsteroidal anti-inflammatory drugs. FASEB J 2005;19:1592–601
- Nivsarkar M, Banerjee A, Padh H. Cyclooxygenase inhibitor: a novel direction for Alzheimer’s management. Pharmacol Rep 2008;60:692–8
- Narsinghani T, Sharma R. Lead optimization on conventional non-steroidal anti-inflammatory drugs: an approach to reduce gastrointestinal toxicity. Chem Biol Drug Des 2014. [Epub ahead of print]. doi: 10.1111/cbdd.12292:1-23
- Spahn H, Langguth P. chiral amines derived from 2-arylpropionic acids: novel reagents for the liquid chromatography (LC) fluorescence assay of optically active carboxylic xenobiotics. Pharm Res 1990;7:1262–8
- Matsunaga N, Kaku T, Akio O, et al. C17, 20-lyase inhibitors. Part 2: Design, synthesis and structure – activity relationships of (2-naphthylmethyl)-1H-imidazoles as novel C17,20-lyase inhibitors. Bioorg Med Chem 2004;12:4313–36
- MacMillan JB, Xiong-Zhou G, Skepper CK, Molinski TF. Phorbasides A-E, cytotoxic chlorocyclopropane macrolide glycosides from the marine sponge Phorbas sp. CD determination of c-methyl sugar configurations. J Org Chem 2008;73:3699–706
- Lee J.-J, Noll BC, Smith BD. Fluorescent chemosensor for chloroalkanes. Org Lett 2008;10:1735–8
- Balsamo A, Coletta I, Domiano P, et al. Synthesis and COX-2 inhibitiory properties on N-Phenyl-and N-benzyl-substituted amides of 2-(4-methylsulfonylphenyl)cyclopent-1-ene-1-carboxylic acid and their pyrazole, thiophene and isoxazole analogs. Eur J Med Chem 2002;37:391–8